WHAT IS UROMEDICA?
Uromedica, Inc. is a Minnesota-based medical device company that has developed a long-term, implantable balloon therapy to treat male and female stress urinary incontinence. ACT® is the female application of our Adjustable Continence Therapy and ProACT™ is the male application. Together they have been implanted in over 16,000 patients worldwide.
Uromedica is committed to developing safe, reliable, and efficacious products in order to continually improve the quality of life of those who use our products.
Uromedica leadership has over twenty years of experience working to perfect our ACT and ProACT systems. We have worked and continue to work with physicians all over the world to bring these systems to the public. With the help of these physicians, we have brought our system to over 16,000 patients worldwide.
If you would like to get in contact with a Uromedica representative, please fill out the information to the right.
1840 Berkshire Ln N
Plymouth, MN 55441
Information provided to us may be used for regulatory reporting but will not otherwise be shared outside of Uromedica. We will respond to your comments or inquiry via email or telephone. Our email response will include your first and last name and will repeat your message to us, which could include personal information about your health. If this is a cause of concern, please call instead of submitting this form.
Looking for more information on the ProACT procedure? Click here.
Looking for more information on the Act procedure? Click here.
Are you a male struggling with male stress urinary incontinence?
Uromedica’s device, ProACT, is a urologic implant indicated to treat all severity levels of stress urinary incontinence in men. Click below to learn more about ProACT. Talk to your physician or use our “Find a Physician” button below to locate a ProACT implanter near you!
Are you a female struggling with stress urinary incontinence?
Uromedica’s device, ACT, is a urological implant designed to treat female patients who have stress urinary incontinence as a result of intrinsic sphincter deficiency or a previously failed surgery. Click below to learn more about our current ACT clinical IDE study.
Caution – The Uromedica ACT system is an INVESTIGATIONAL DEVICE, LIMITED BY FEDERAL (OR UNITED STATES) LAW TO INVESTIGATIONAL USE. The ACT System is not available for sale in the United States.
The Uromedica ACT system has received European CE Mark approval, Canadian licensing, and is listed on the Australian Register of Therapeutic Goods for treatment of stress urinary incontinence and is available for sale in Europe, Canada and Australia.